Anamaria Tomșa

Dr. Anamaria Tomșa


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
ATAnamaria Tomșa
Anamaria Tomșa
A(Andreea-Liana Boț (Răchișan)
Andreea-Liana Boț (Răchișan)
SPStanca-Lucia Pandrea
Stanca-Lucia Pandrea
ABAndreea Benea
Andreea Benea
AUAna Uifălean
Ana Uifălean
LJLia Monica Junie
Lia Monica Junie
Gentamicin remains widely used in all age groups despite its well-documented nephrotoxicity; however, no adjuvant therapies have been established to counteract this side effect. Our study aimed to experimentally determine whether curcumin and vitamin C have nephroprotective effects and whether certain reactive species could be used as markers of early gentamicin nephrotoxicity. Wistar adult male rats were evenly distributed into four groups: control, gentamicin, curcumin and gentamicin, vitamin C and gentamicin (gentamicin: 60 mg/kg/day, intraperitoneally, 7 days). We determined renal function (urea, creatinine), oxidative stress (malondialdehyde, nitric oxide, 3-nitrotyrosine, total oxidative stress), and antioxidant and anti-inflammatory status (thiols, total antioxidant capacity, interleukin-10). Nephrotoxicity was successfully induced, as shown by the elevated creatinine levels in the gentamicin group. In contrast, supplementation with curcumin and vitamin C prevented an increase in urea levels while decreasing total oxidative stress levels compared to the gentamicin group. Moreover, vitamin C and curcumin distinctively modulate the levels of nitric oxide and malondialdehyde. Histological analysis showed more discrete lesions in rats that received vitamin C compared to the curcumin group.

26 August 2021 in Experimental and Therapeutic Medicine
Verified
Journal Article
Closed access
PDF file
ATAnamaria Tomșa
Anamaria Tomșa
ARAndreea Liana Răchişan
Andreea Liana Răchişan
SPStanca Lucia Pandrea
Stanca Lucia Pandrea
ABAndreea Benea
Andreea Benea
AUAna Uifălean
Ana Uifălean
LJLia Monica Junie
Lia Monica Junie
Kidney disease represents a burden for the health care system worldwide. As the prevalence continues to rise, discovering new biomarkers of early kidney damage has become crucial. Oxidative stress (OS) represents one of the main factors involved in the early stages of many syndromes leading to kidney damage. Therefore, it must be studied in detail. To date, many studies have focused on OS in advanced stages of acute kidney injury (AKI), with great success. The aim of the present study was to ascertain whether even mild renal function impairment can be linked to specific systemic markers of OS and systemic antioxidants in order to pinpoint certain biomarkers for early kidney damage. We used male rats (Rattus norvegicus) in which we induced kidney damage by injecting gentamicin for 7 days. Blood was collected 24 h after the last dose of gentamicin. Urea, creatinine, 3‑nitrotyrosine (3‑NT), nitric oxide (NO), malondialdehyde (MDA), thiols (TS), total oxidative stress (TOS), and interferon‑γ (IFN‑γ) were determined. In addition, for the antioxidant status we measured total antioxidant capacity (TAC) and interleukin‑10 (IL‑10). Our results demonstrated that the rats had mild renal impairment consistent with a pre‑AKI stage due to the nephrotoxic effect of gentamicin. However, TOS, MDA and NO were significantly higher in the gentamicin group compared to the control group. In addition, TAC was higher in the control group. Hence, OS markers reach higher levels and may potentially be used as markers of kidney damage even in cases of mild renal function impairment.